MSB 2.08% 94.0¢ mesoblast limited

LOL, OP againdiscrediting an author because of conflict of...

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    LOL, OP again
    discrediting an author because of conflict of interests, I see, that's why he wrote all those comments on the P2 (which seems to have carried on to the P3). Thanks for clearing that up....just like those docs on CHF trial.....I knew it. Too easy.

    "The back pain treatment is a simple procedure involving 6m cells being injected in an outpatient clinic for at least 3 years major pain relief avoiding spinal fusion surgery. What is not to like about that?"

    well, it doesn't seem to regenerate any disk (DDD) of any meaning which was the original plan and claims.....so what's not to like about it? It's an expensive pain killer that doesn't seem to do much to the underlying issue as stems cells are supposed to do, so surgery has only been delayed by a little.

    So, how much will this all cost for shot?
    will be the biggest issue
    as SRock said, they will need to improve that manufacturing and COGs quick smart if this quick Phase 3 (yes, it looks easier this time) goes ahead.

    Sales of this treatment?
    2025?
    Low margin likely
    Not a blockbuster as promised early days

    Last edited by Sector: 12/01/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.